Heme oxygenase-1 protects regulatory T cells from hypoxia-induced cellular stress in an experimental mouse brain tumor model

Journal of Neuroimmunology

Volumn 266, Issue 1-2, 2014, Pages 33-42

  Dey, Mahua ^a   Chang, Alan L ^a   Wainwright, Derek A ^a   Ahmed, Atique U ^a   Han, Yu ^a   Balyasnikova, Irina V ^a   Lesniak, Maciej S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Glioma; Heme oxygenase 1; Hypoxia; Immunization; Regulatory T cells; Tin protoporphyrin

Indexed keywords

GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; HEME OXYGENASE 1; INTERLEUKIN 10; PROTOPORPHYRIN TIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TUMOR; CD4+ T LYMPHOCYTE; CELL DEATH; CELL HYPOXIA; CELL PROTECTION; CELL STRESS; CELLULAR DISTRIBUTION; ENZYME INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; SURVIVAL TIME; TUMOR MICROENVIRONMENT; TUMOR MODEL;

EID: 84891484160     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2013.10.012     Document Type: Article

References (48)

1. Braudeau C., Bouchet D., Tesson L., Iyer S., Remy S., Buelow R., Anegon I., Chauveau C. Induction of long-term cardiac allograft survival by heme oxygenase-1 gene transfer. Gene Ther. 2004, 11:701-710.
2. Chen K., Gunter K., Maines M.D. Neurons overexpressing heme oxygenase-1 resist oxidative stress-mediated cell death. J. Neurochem. 2000, 75:304-313.
3. Chora A.A., Fontoura P., Cunha A., Pais T.F., Cardoso S., Ho P.P., Lee L.Y., Sobel R.A., Steinman L., Soares M.P. Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation. J. Clin. Invest. 2007, 117:438-447.
4. Corthay A. How do regulatory T cells work?. Scand. J. Immunol. 2009, 70:326-336.
5. Crane C.A., Ahn B.J., Han S.J., Parsa A.T. Soluble factors secreted by glioblastoma cell lines facilitate recruitment, survival, and expansion of regulatory T cells: implications for immunotherapy. Neuro Oncol. 2012, 14:584-595.
6. Do M.T., Kim H.G., Khanal T., Choi J.H., Kim D.H., Jeong T.C., Jeong H.G. Metformin inhibits heme oxygenase-1 expression in cancer cells through inactivation of Raf-ERK-Nrf2 signaling and AMPK-independent pathways. Toxicol. Appl. Pharmacol. 2013, 271:229-238.
7. Doi K., Akaike T., Fujii S., Tanaka S., Ikebe N., Beppu T., Shibahara S., Ogawa M., Maeda H. Induction of haem oxygenase-1 nitric oxide and ischaemia in experimental solid tumours and implications for tumour growth. Br. J. Cancer 1999, 80:1945-1954.
8. Drummond G.S. Control of heme metabolism by synthetic metalloporphyrins. Ann. N. Y. Acad. Sci. 1987, 514:87-95.
9. + T-cell infiltration and heme oxygenase-1 expression correlate with tumor grade in human gliomas. J. Neurooncol. 2007, 83:145-152.
10. + regulatory T cells in mice with experimental brain tumors. J. Neurosurg. 2006, 105:430-437.
11. Evans S.M., Judy K.D., Dunphy I., Jenkins W.T., Hwang W.T., Nelson P.T., Lustig R.A., Jenkins K., Magarelli D.P., Hahn S.M., Collins R.A., Grady M.S., Koch C.J. Hypoxia is important in the biology and aggression of human glial brain tumors. Clin. Cancer Res. 2004, 10:8177-8184.
12. Facciabene A., Peng X., Hagemann I.S., Balint K., Barchetti A., Wang L.P., Gimotty P.A., Gilks C.B., Lal P., Zhang L., Coukos G. Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells. Nature 2011, 475:226-230.
13. Fang J., Sawa T., Akaike T., Akuta T., Sahoo S.K., Khaled G., Hamada A., Maeda H. In vivo antitumor activity of pegylated zinc protoporphyrin: targeted inhibition of heme oxygenase in solid tumor. Cancer Res. 2003, 63:3567-3574.
14. Fecci P.E., Mitchell D.A., Whitesides J.F., Xie W., Friedman A.H., Archer G.E., Herndon J.E., Bigner D.D., Dranoff G., Sampson J.H. Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma. Cancer Res. 2006, 66:3294-3302.
15. + regulatory T cells is dependent on expression of heme oxygenase-1 in antigen-presenting cells. Am. J. Pathol. 2008, 173:154-160.
16. Gozzelino R., Jeney V., Soares M.P. Mechanisms of cell protection by heme oxygenase-1. Annu. Rev. Pharmacol. Toxicol. 2010, 50:323-354.
17. + regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo. Int. J. Cancer 2007, 121:95-105.
18. Huang E., Ong W.Y., Go M.L., Garey L.J. Heme oxygenase-1 activity after excitotoxic injury: immunohistochemical localization of bilirubin in neurons and astrocytes and deleterious effects of heme oxygenase inhibition on neuronal survival after kainate treatment. J. Neurosci. Res. 2005, 80:268-278.
19. Iwadate Y., Yamaura A., Sakiyama S., Sato Y., Tagawa M. Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production. Int. J. Oncol. 2003, 23:483-488.
20. Jacobs J.F., Idema A.J., Bol K.F., Grotenhuis J.A., de Vries I.J., Wesseling P., Adema G.J. Prognostic significance and mechanism of Treg infiltration in human brain tumors. J. Neuroimmunol. 2010, 225:195-199.
21. James C.D. Stimulating anti-tumor immune response: the problem of regulatory T-cells. Neuro Oncol. 2011, 13:1261.
22. Jensen R.L. Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target. J. Neurooncol. 2009, 92:317-335.
23. Kappas A., Drummond G.S. Control of heme metabolism with synthetic metalloporphyrins. J. Clin. Invest. 1986, 77:335-339.
24. Khelifi A.F., Prise V.E., Tozer G.M. Effects of tin-protoporphyrin IX on blood flow in a rat tumor model. Exp. Biol. Med. (Maywood) 2003, 228:481-485.
25. + regulatory T cell suppression of dendritic cell function involves TGF-beta and IL-10. Cancer Immunol. Immunother. 2007, 56:48-59.
26. Lee T.S., Chau L.Y. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat. Med. 2002, 8:240-246.
27. Lee S.E., Yang H., Jeong S.I., Jin Y.H., Park C.S., Park Y.S. Induction of heme oxygenase-1 inhibits cell death in crotonaldehyde-stimulated HepG2 cells via the PKC-delta-p38-Nrf2 pathway. PLoS One 2012, 7:e41676.
28. Lesniak M.S. Immunotherapy for glioblastoma: the devil is in the details. J. Clin. Oncol. 2011, 29:3105. (author reply 3105-3106).
29. Liu Y., Zhang Z., Luo B., Schluesener H.J. Lesional accumulation of heme oxygenase-1+ microglia/macrophages in rat traumatic brain injury. Neuroreport 2013, 24:281-286.
30. Lokhov P.G., Balashova E.E. Cellular cancer vaccines: an update on the development of vaccines generated from cell surface antigens. J. Cancer 2010, 1:230-241.
31. Metz R., Duhadaway J.B., Rust S., Munn D.H., Muller A.J., Mautino M., Prendergast G.C. Zinc protoporphyrin IX stimulates tumor immunity by disrupting the immunosuppressive enzyme indoleamine 2,3-dioxygenase. Mol. Cancer Ther. 2010, 9:1864-1871.
32. Moreau A., Hill M., Thebault P., Deschamps J.Y., Chiffoleau E., Chauveau C., Moullier P., Anegon I., Alliot-Licht B., Cuturi M.C. Tolerogenic dendritic cells actively inhibit T cells through heme oxygenase-1 in rodents and in nonhuman primates. FASEB J. 2009, 23:3070-3077.
33. Mougiakakos D., Johansson C.C., Kiessling R. Naturally occurring regulatory T cells show reduced sensitivity toward oxidative stress-induced cell death. Blood 2009, 113:3542-3545.
34. Naujocks G., Schmitz A., Schramm J., Wiestler O., Schirrmacher V. Peripheral immunization against malignant rat glioma can induce effective antitumor immunity in the brain. Int. J. Oncol. 1995, 6:759-765.
35. Nocentini G., Riccardi C. GITR: a multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily. Eur. J. Immunol. 2005, 35:1016-1022.
36. Ronchetti S., Nocentini G., Riccardi C., Pandolfi P.P. Role of GITR in activation response of T lymphocytes. Blood 2002, 100:350-352.
37. Ronchetti S., Zollo O., Bruscoli S., Agostini M., Bianchini R., Nocentini G., Ayroldi E., Riccardi C. GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations. Eur. J. Immunol. 2004, 34:613-622.
38. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 1995, 155:1151-1164.
39. Schumacher A., Wafula P.O., Teles A., El-Mousleh T., Linzke N., Zenclussen M.L., Langwisch S., Heinze K., Wollenberg I., Casalis P.A., Volk H.D., Fest S., Zenclussen A.C. Blockage of heme oxygenase-1 abrogates the protective effect of regulatory T cells on murine pregnancy and promotes the maturation of dendritic cells. PLoS One 2012, 7:e42301.
40. + regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 2002, 3:135-142.
41. Soares M.P., Bach F.H. Heme oxygenase-1: from biology to therapeutic potential. Trends Mol. Med. 2009, 15:50-58.
42. Visse E., Siesjo P., Widegren B., Sjogren H.O. Regression of intracerebral rat glioma isografts by therapeutic subcutaneous immunization with interferon-gamma, interleukin-7, or B7-1-transfected tumor cells. Cancer Gene Ther. 1999, 6:37-44.
43. Wainwright D.A., Sengupta S., Han Y., Lesniak M.S. Thymus-derived rather than tumor-induced regulatory T cells predominate in brain tumors. Neuro Oncol. 2011, 13:1308-1323.
44. Wainwright D.A., Balyasnikova I.V., Chang A.L., Ahmed A.U., Moon K.S., Auffinger B., Tobias A.L., Han Y., Lesniak M.S. IDO expression in brain tumors increases the recruitment of regulatory T cells and negatively impacts survival. Clin. Cancer Res. 2012, 18:6110-6121.
45. Wainwright D.A., Dey M., Chang A., Lesniak M.S. Targeting Tregs in malignant brain cancer: overcoming IDO. Front. Immunol. 2013, 4:116.
46. Wei J., Wu A., Kong L.Y., Wang Y., Fuller G., Fokt I., Melillo G., Priebe W., Heimberger A.B. Hypoxia potentiates glioma-mediated immunosuppression. PLoS One 2011, 6:e16195.
47. Xia Z.W., Zhong W.W., Meyrowitz J.S., Zhang Z.L. The role of heme oxygenase-1 in T cell-mediated immunity: the all encompassing enzyme. Curr. Pharm. Des. 2008, 14:454-464.
48. Zelenay S., Chora A., Soares M.P., Demengeot J. Heme oxygenase-1 is not required for mouse regulatory T cell development and function. Int. Immunol. 2007, 19:11-18.